SCHEMBL3845296

SCHEMBL3845296

O=C(Nc1c(F)cccc1F)c1ccc(-c2cnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cn23)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHB3 P54753 1/20 0.38
KDR P35968 3/20 0.36
FGFR3 P22607 2/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
FYN P06241 1/20 0.35
RIPK2 O43353 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
CLK1 P49759 5/20 0.34
MC4R P32245 1/20 0.33
CHRNA7 P36544 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
MET P08581 2/20 0.33
PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846174 0.92 EPHB3 (0.39) EPHB3KDRFGFR3SMN1; SMN2MKNK1
SCHEMBL3849103 0.88 EPHB3 (0.40) EPHB3KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL3848378 0.88 EPHB3 (0.38) EPHB3KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL3849284 0.84 EPHB3 (0.38) EPHB3KDRFGFR3MKNK1MKNK2
SCHEMBL3846926 0.84 SORT1 (0.42) EPHB3NPC1RAB9ASMN1; SMN2MKNK1
SCHEMBL3845229 0.83 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2MKNK1MKNK2
SCHEMBL3850098 0.83 EPHB3 (0.39) EPHB3KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL3848640 0.83 KCNQ3 (0.39) EPHB3CLK1MET
SCHEMBL3847097 0.82 PRMT5 (0.38) KDRFGFR3MKNK1MKNK2CLK1
SCHEMBL3851209 0.81 PIK3CA (0.42) EPHB3KDRFGFR3KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed